Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Collaboration helps multiple sclerosis patients track symptoms

  • medicalxpress.com language
  • 2025-07-21 21:00 event
  • 1 month ago schedule
Collaboration helps multiple sclerosis patients track symptoms
Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on artificial intelligence that may help people with multiple sclerosis track their symptoms—and even predict them.

1.555. Low vitamin D may increase your risk of being hospitalized with COVID-19

  • 1 month ago schedule
  • medicalxpress.com language

As the latest wave of COVID-19 shows no signs of abating, University of South Australia experts say it's not just booster shots that could offer protection—healthy levels of vitamin D may also play a role.

1.556. Largest database of brain tumor gene expression created to speed discovery of new treatments

  • 1 month ago schedule
  • medicalxpress.com language

A new online tool developed by researchers at the University of Louisville promises to speed up the discovery of treatments for brain and nerve tumors, especially rare ones that have had limited research attention.

1.557. Why some people persist in harmful behaviors—even when they know where they're going wrong

  • 1 month ago schedule
  • medicalxpress.com language

Why do some people keep making choices that hurt them, even when the outcomes are obvious?

1.558. GLP-1 drugs fail to provide key long-term health benefit, study shows

  • 1 month ago schedule
  • medicalxpress.com language

Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in heart and lung function essential for long-term good health, University of Virginia experts warn in a new paper.

1.559. Even grave errors at rehab hospitals go unpenalized and undisclosed, analysis finds

  • 1 month ago schedule
  • medicalxpress.com language

Rehab hospitals that help people recover from major surgeries and injuries have become a highly lucrative slice of the health care business. But federal data and inspection reports show that some run by the dominant company, Encompass Health Corp., and other for-profit corporations have had rare but serious incidents of patient harm and perform below average on two key safety measures tracked by Medicare.

1.560. Patients have reservations about physicians who use artificial intelligence, according to study

  • 1 month ago schedule
  • medicalxpress.com language

People view physicians more negatively who disclose the use of artificial intelligence in their practice. This is the conclusion of a new study by psychologists from Würzburg published in JAMA Network Open.

1.561. Recommended immunization schedules explained

  • 1 month ago schedule
  • medicalxpress.com language

Experts in vaccines and vaccination—including pediatricians—work together throughout the year to update the Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger.

1.562. New theory suggests attention flickers between competing sights like a strobe light

  • 1 month ago schedule
  • medicalxpress.com language

When you look at the world around you, it might feel like your eyes and brain work in perfect sync—taking in a smooth, continuous stream of information. But according to new research led by cognitive neuroscientist Prof. Ayelet N. Landau from the Hebrew University of Jerusalem, that's not quite how the brain works. Instead, attention behaves more like a strobe light: flickering in and out at a steady rhythm.

1.563. Research identifies genetic predictor of weight loss with GLP-1RAs

  • 1 month ago schedule
  • medicalxpress.com language

A new study published by Cleveland Clinic researchers in Diabetes, Obesity and Metabolism investigating the genetic underpinnings of weight loss response has identified a gene, neurobeachin (NBEA), as a predictor of how individuals respond to GLP-1RAs, the class of medications behind popular treatments like liraglutide and semaglutide.

1.564. Collaboration helps multiple sclerosis patients track symptoms

  • 1 month ago schedule
  • medicalxpress.com language

Researchers at the University of Pittsburgh and Carnegie Mellon University collaborated to create a customized app based on artificial intelligence that may help people with multiple sclerosis track their symptoms—and even predict them.

1.565. Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery

  • 1 month ago schedule
  • medicalxpress.com language

Accurate removal of tumors is the most critical aspect of cancer surgery, yet it remains a significant challenge in clinical practice. In breast cancer, for example, the positive margin rate—where cancer cells remain at the surgical boundary—can reach up to 35%, often requiring reoperation and increasing the risk of recurrence.

1.566. Immune cells turn into 'mini-Hulks' to push away tissue and make space when migrating

  • 1 month ago schedule
  • medicalxpress.com language

Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable three-dimensional tissues that make up our bodies.

1.567. Predicting kidney disease trajectories with a simple blood test

  • 1 month ago schedule
  • medicalxpress.com language

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited condition that can lead to kidney failure. Being able to accurately predict how the disease will progress is very important for selecting the right treatments and providing effective patient counseling. However, the currently available prediction tools aren't very accurate and require MRI images or genetic exams, which are not always available.

1.568. Immigration crackdown could stymie efforts to fight bird flu outbreak, experts fear

  • 1 month ago schedule
  • medicalxpress.com language

As authorities brace for a potential resurgence in bird flu cases this fall, infectious disease specialists warn that the Trump administration's crackdown on undocumented immigrants could hamper efforts to stop the spread of disease.

1.569. Gecko-inspired cancer therapy could lead to fewer side-effects, better patient outcomes

  • 1 month ago schedule
  • medicalxpress.com language

As far back as the 4th Century B.C., Aristotle marveled at the nimble gecko's ability to "run up and down a tree in any way, even with the head downwards."

1.570. 2020 to 2024 saw drop in flu vaccine uptake among U.S. adults

  • 1 month ago schedule
  • medicalxpress.com language

There was an overall decrease in influenza vaccine uptake among U.S. adults from 2020 to 2024, according to a study published online in PLOS Global Public Health.

1.571. The Lancet Commission calls for global policy shift—One Health as the key to the future

  • 1 month ago schedule
  • medicalxpress.com language

The world is facing an interconnected health crisis: zoonoses, antimicrobial resistance, environmental degradation, and climate change threaten millions of lives. An international expert group, The Lancet One Health Commission, warns in its first report of severe consequences if governments, business, and international organizations fail to change course immediately.

1.572. Study reveals how inhibitory neurons and astrocytes control brain blood flow

  • 1 month ago schedule
  • medicalxpress.com language

Researchers at the Center for Neuroscience Imaging Research within the Institute for Basic Science (IBS) have uncovered a two-step mechanism by which the brain regulates blood volume—a breakthrough with significant implications for how scientists understand and interpret functional magnetic resonance imaging (fMRI).

1.573. A shared five biomarker profile across four major neurodegenerative diseases

  • 1 month ago schedule
  • medicalxpress.com language

The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts to identify patterns in neurodegenerative disease. Sifting through roughly 250 million plasma measurements, they have discovered a five-protein panel present in APOE ε4 carriers across Alzheimer's disease, Parkinson's disease, frontotemporal dementia and amyotrophic lateral sclerosis.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.